EP95 Medical Innovation Policy and the COVID Vaccine with Jocelyn Ulrich

Jocelyn Ulrich is a GPH alumna who graduated with a concentration in global health policy and management in 2009. Jocelyn has over 15 years of experience in the pharmaceutical industry and currently works as a Deputy Vice President in Medical Innovation Policy in the Policy and Research department at PhRMA, the Pharmaceutical Researchers and Manufacturers of America. In this role, she works at the intersection of public health and public policy to develop legislative and policy analysis and research studies on a range of issues impacting innovative biopharmaceutical companies ranging from FDA policy and intellectual property concerns. Jocelyn is dedicated to advancing medical innovation policy and in this episode, she discusses the function of her role at PhRMA, interesting innovations in health she's excited about, as well as her thoughts on the COVID-19 vaccine in terms of vaccine confidence and how efforts are being made to be inclusive of all communities, especially marginalized groups, in vaccine rollout and healthcare as a whole. To learn more about the NYU School of Global Public Health, and how our innovative programs are training the next generation of public health leaders, visit publichealth.nyu.edu.